about
CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma.Measurement of the invasion depth of extrahepatic bile duct carcinoma: An alternative method overcoming the current T classification problems of the AJCC staging system.DPC4 expression in the small intestinal adenocarcinomas.Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma.Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.Xanthogranulomatous cholecystitis shows overlapping histological features with IgG4-related cholecystitis.MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.Increased number of metastatic lymph nodes in adenocarcinoma of the ampulla of Vater as a prognostic factor: a proposal of new nodal classification.Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases.Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential.Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas.HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile ductInvasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinomap63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significanceAnalysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patientsSuperficial vs deep pancreatic parenchymal invasion in the extrahepatic bile duct carcinomas: a significant prognostic factor
P50
Q30438178-58FCE3C7-FBE4-4BA4-8C89-D870CC7D8DCEQ30442740-943B29CD-E83E-4408-9912-481EFAB2B7FDQ36374593-A4A93778-13A0-4B03-A238-840CB8F92793Q40901008-A01E0C41-0432-4F8D-948A-8B150E391883Q42220401-A5F3EA0E-178F-4483-8FA3-00785FA5B821Q44007028-026B84A6-D845-460C-8728-7E915FC2D08FQ48201212-DD8BE4A6-BD76-4C76-9F08-C82FA33CCEEFQ50139704-9AD9465C-CCB5-4E2A-94E6-9A588982C191Q51141072-56E1754D-2EEF-444C-ACAD-474AF7B0FF69Q51575529-C28FD287-5616-4FE7-8CAD-58DAB5A818DBQ53079425-612225CA-D902-4C4A-8264-0851F412ED49Q53272229-BB481BCC-B730-4820-95C7-E02755D8FD6CQ54478596-D7A4B2CE-F017-490C-939C-D02F84E9C5E8Q56928089-0F77E6F4-35FC-4D00-A204-4E7E9764E0DBQ56928090-7C4173A1-03A7-4B5C-AEA7-5A7891FCA731Q56928094-44B5DF4C-6A44-463E-880B-459E2449100AQ56928095-E5526DAB-8F71-4B7D-9415-7EF808618BB6Q56928096-213115B0-5E06-4836-AAD4-583BD106D954
P50
name
Eunsil Yu
@ast
Eunsil Yu
@en
Eunsil Yu
@nl
type
label
Eunsil Yu
@ast
Eunsil Yu
@en
Eunsil Yu
@nl
prefLabel
Eunsil Yu
@ast
Eunsil Yu
@en
Eunsil Yu
@nl